SUD APCM Care Plan Creation Workflow | Tile
Optimize your Substance Use Disorder APCM care plan creation with 42 CFR Part 2 compliance and AI-driven MAT monitoring workflows.
Creating effective Advanced Primary Care Management (APCM) care plans for Substance Use Disorders requires balancing clinical efficacy with strict 42 CFR Part 2 confidentiality. This guide outlines a structured workflow to integrate AI-powered patient monitoring, MAT adherence tracking, and 2026 BHI add-on codes into a cohesive care strategy for OUD and AUD patients.
SUD practices struggle with high dropout rates and the administrative burden of 42 CFR Part 2 compliance. Traditional care planning often fails to capture the continuous monitoring required for MAT or the nuances of co-occurring mental health conditions, leading to lost revenue.
Step-by-Step Workflow
Initial Screening & 42 CFR Part 2 Consent
Utilize AI-automated outreach to gather initial screening data and secure digital consents specifically formatted for 42 CFR Part 2 compliance. This ensures all subsequent care management data is legally protected.
- Use time-limited consent forms
- Automate the re-authorization process
- Using generic HIPAA forms for SUD records
- Failing to document specific disclosure purposes
Risk Stratification & MAT Baseline
Assess OUD/AUD severity and establish MAT baseline metrics. AI tools can analyze previous treatment history to trigger specific APCM monitoring frequencies based on patient stability and relapse risk.
- Identify high-risk detox follow-up windows
- Log baseline buprenorphine dosages
- Ignoring history of overdose in risk scoring
- Static care plans that don't adjust for stability
Co-occurring Disorder Integration
Identify depression, anxiety, or chronic pain symptoms using automated PHQ-9 and GAD-7 triggers. This data is essential to qualify for the 2026 BHI add-on codes (G0568-G0570) for SUD patients.
- Automate PHQ-9 delivery every 30 days
- Link pain management to OUD monitoring
- Treating SUD in isolation from mental health
- Missing documentation for BHI revenue capture
Automated MAT Adherence Workflows
Configure AI call triggers for weekly MAT adherence checks and naloxone availability verification. These touchpoints ensure patient safety and provide the continuous care required for APCM billing.
- Ask about pharmacy access barriers
- Confirm naloxone kit expiration dates
- Waiting for the next in-person visit to check adherence
- Inconsistent monitoring of pharmacy fill dates
Relapse Prevention & Crisis Routing
Establish structured relapse prevention protocols within the care plan. AI call handling can identify 'cravings' or 'triggers' in patient speech and route these high-risk responses to clinical staff.
- Set up 24/7 emergency clinical routing
- Include family support contacts in the plan
- Lack of immediate intervention for high-risk flags
- Vague crisis instructions in the care plan
Final APCM Documentation & Revenue Audit
Aggregate all AI-collected monitoring data into the EHR to finalize the APCM care plan. Ensure all 2026 billing requirements for G0568-G0570 are met, including the required care management minutes.
- Audit minutes spent on non-face-to-face care
- Link every care plan goal to a billing code
- Under-reporting time spent on care coordination
- Incomplete EHR documentation for Medicare audits
Expected Outcomes
Increased APCM enrollment rates through automated outreach
Full 42 CFR Part 2 compliance for all patient communications
Higher MAT adherence and retention in OUD/AUD programs
Maximum capture of 2026 BHI add-on revenue (G0568-G0570)
Reduced administrative burden on clinical staff
Frequently Asked Questions
AI systems must be configured with specific consent logic that ensures SUD records are not disclosed without explicit, time-limited patient authorization, separate from standard HIPAA.
Codes G0568-G0570 allow for additional reimbursement when managing co-occurring mental health conditions within an APCM framework for SUD patients.
Yes, AI can automate refill coordination and pharmacy verification, reducing the risk of treatment gaps in buprenorphine or methadone protocols.
Ready to transform your substance use disorders practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo